['Limited data exist on the prognosis of preoperative Helicobacter pylori (H. pylori) infection in gastric adenocarcinoma (GAC).', 'Patients who underwent curative-intent resection for GAC from 2000 to 2012 at seven academic institutions comprising the United States Gastric Cancer Collaborative were included in the study. The primary end points of the study were overall survival (OS), recurrence-free survival (RFS), and disease-specific survival (DSS).', 'Of 559 patients, 104 (18.6\xa0%) who tested positive for H. pylori were younger (62.1 vs 65.1\xa0years; p\xa0=\xa00.041), had a higher frequency of distal tumors (82.7 vs 71.9\xa0%; p\xa0=\xa00.033), and had higher rates of adjuvant radiation therapy (47.0 vs 34.9\xa0%; p\xa0=\xa00.032). There were no differences in American Society of Anesthesiology (ASA) class, margin status, grade, perineural invasion, lymphovascular invasion, nodal metastases, or tumor-node-metastasis (TNM) stage. H. pylori positivity was associated with longer OS (84.3 vs 44.2\xa0months; p\xa0=\xa00.008) for all patients. This relationship with OS persisted in the multivariable analysis (HR 0.54; 95\xa0% CI 0.30-0.99; p\xa0=\xa00.046). H. pylori was not associated with RFS or DSS in all patients. In the stage 3 patients, H. pylori was associated with longer OS (44.5 vs 24.7\xa0months; p\xa0=\xa00.018), a trend of longer RFS (31.4 vs 21.6\xa0months; p\xa0=\xa00.232), and longer DSS (44.8 vs 27.2\xa0months; p\xa0=\xa00.034).'] Is preoperative Helicobacter pylori Infection Associated with Increased Survival After Resection of Gastric Adenocarcinoma?